Viewing Study NCT00622258


Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2026-01-04 @ 11:31 PM
Study NCT ID: NCT00622258
Status: COMPLETED
Last Update Posted: 2020-12-21
First Post: 2008-02-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Dose Escalation Study of RAD001 Administered in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module